Table 5 A table indicating antibiotic use in all infants with suspected infection
| Â | N | % |
|---|---|---|
Total participants with infection | 55 | 100 |
Total antibiotic exposure | 22 | 40.0 (27.0:54.1) |
Sources of evidence for antibiotic use | ||
 Clinical notes | 17 | 30.9 (19.1:44.8) |
 Direct question addressing use of any medication on IMCI form | 3 | 5.5 (1.1:15.1) |
 Comments on antibiotic use (free text) | 19 | 34.5 (22.2:48.6) |
Total antibiotic exposures | 52* | 100 |
Named antibiotic | ||
 Amoxicillin | 8 | 15.4 (6.9:28.1) |
 Ceftriaxone | 10 | 19.2 (9.6:32.5) |
 Gentamycin | 7 | 13.5 (5.6:25.8) |
 Metronidazole | 3 | 5.8 (1.2:15.9) |
 Ampiclox | 4 | 7.7 (2.1:18.5) |
 Nalidixic acid | 1 | 1.9 (0.1:10.3) |
 Ampicillin | 4 | 7.7 (2.1:18.5) |
 Cloxacillin | 2 | 3.8 (0.5:13.2) |
 Benzyl penicillin | 2 | 3.8 (0.5:13.2) |
 Co-trimoxazole | 6 | 11.5 (4.4:23.4) |
 Neomycin | 1 | 1.9 (0.1:10.3) |
 Amikacin | 1 | 1.9 (0.1:10.3) |
 Mupirocin | 1 | 1.9 (0.1:10.3) |
 Tetracycline | 1 | 1.9 (0.1:10.3) |
 Erythromycin | 1 | 1.9 (0.1:10.3) |